T.J.C. van Terwisga is a Professor at the Ship Hydromechanics and Structures department of Delft University of Technology (Faculty of Mechanical, Maritime and Materials Engineering). His research focuses on cavitation phenomena, vortical flows, and microbubble dynamics, with applications in ship hydrodynamics and marine technology. PhD in Mechanical Engineering (specialization in cavitation physics) Editorial Board Member: The Journal of Ocean Technology (2006–present) Research Interests : Cavitation inception and erosion mechanisms Air lubrication systems for ship drag reduction Underwater shipping noise propagation Bubble dynamics in vortical flows Experimental fluid mechanics Hydrofoil performance optimization Scientific Contributions : Developed advanced calibration methods for microbubble measurement systems Investigated air lubrication regime transitions under varying flow conditions Studied cavitation onset in counter-rotating vortex flows Explored bubble capture mechanisms in vortical flows Contributed to underwater soundscape modeling for maritime operations Editorial Roles : Editor, The Journal of Ocean Technology (2006–present) Editor, The Journal of Ocean Technology (2009–present)
Sabrina Santos Oliveira is an Associate Professor with a shared position between the Cell Biology, Neurobiology and Biophysics division of the Department of Biology and the Pharmaceutics division of the Department of Pharmaceutical Sciences at Utrecht University's Faculty of Science. Her research focuses on Molecular Targeted Therapies, particularly using nanobodies to enhance the selectivity of photodynamic therapy for cancer treatment. Dr. Oliveira received her initial introduction to Utrecht University through an internship at the Department of Pharmaceutical Sciences in 2004 during her studies at the Faculty of Pharmacy of Coimbra University in Portugal. After graduation, she obtained an individual doctoral grant from the Portuguese Foundation for Science and Technology (FCT) to complete her PhD research on Targeted Cancer Therapies (2004-2008). She then worked as a postdoc on nanobody-based tracers for optical molecular imaging (2008-2012). In 2012, she was awarded a VENI grant from the Netherlands Organisation for Research (NWO-STW), which allowed her to start her own research line focused on rendering photodynamic therapy more selective to cancer cells using nanobodies. In 2016, she received a Starting Grant from the European Research Council (ERC) to continue her research. She was appointed Assistant Professor in July 2016 and Associate Professor in May 2019. Dr. Oliveira's research group focuses on developing and evaluating improved therapies directed at relevant molecular targets. Her work primarily centers on nanobody-targeted photodynamic therapy, which uses the small size and binding specificity of nanobodies to target photosensitizers specifically to cancer cells. This approach aims to improve the selectivity of photodynamic therapy, which is currently limited by the non-specific interaction of hydrophobic photosensitizers with all cell types. Her ERC-funded KILLCANCER project (Starting Grant #677582) has investigated the mechanism of nanobody-targeted PDT and evaluated this approach in larger animals, with the goal of translating findings to human patients. The research has potential applications in treating various cancers, including feline oral carcinoma, which is being studied in collaboration with the University Clinic for Companion Animal Health. Analysis of Dr. Oliveira's recent publications reveals a strong focus on translating nanobody technology from basic research to clinical applications. Her work spans multiple therapeutic areas including cancer treatment, viral infection therapies, and advanced drug delivery systems. The research demonstrates significant translational potential, with applications in both human and veterinary medicine, particularly in improving cancer treatment options through more selective targeting approaches. VENI grant from Netherlands Organisation for Research (NWO-STW) (2012) Starting Grant from European Research Council (ERC) (2016) Individual doctoral grant from Portuguese Foundation for Science and Technology (FCT) Dr. Oliveira's laboratory includes a technician, multiple postdocs, and PhD students working on various aspects of nanobody-targeted therapies. Her research has been highlighted by the Morris Animal Foundation as a promising new treatment for cats suffering from oral squamous cell carcinoma, demonstrating the translational potential of her work from bench to bedside (and clinic). The collaborative nature of her research is evident in the numerous collaborations with other departments and institutions, including the University Medical Center Utrecht and veterinary clinics.
Professor Xiaowei Wang is a leading academic at the Baker Heart and Diabetes Institute , where she heads the Molecular Imaging and Nanotherapeutics laboratory and co-leads the Heart Attack Program and Centre for Cardiometabolic mRNA Therapy . She holds adjunct and honorary academic appointments at the University of Melbourne, La Trobe University, Monash University, Swinburne University, and Torrens University. Professor Wang earned her PhD from Monash University and is a Fellow of the Australian Academy of Health Sciences (FAHA), Cardiac Society of Australia and New Zealand (FCSANZ), and European Society of Cardiology (FESC). Her research integrates physics, chemistry, biology, and biotechnology to develop clinical-ready diagnostic and therapeutic solutions for cardiovascular disease. Her work focuses on preclinical molecular imaging using advanced technologies like MRI, PET, and photoacoustic imaging to enable early diagnosis and real-time monitoring of treatments. She pioneers mRNA therapeutics and vaccines delivered via micro- and nano-particles to prevent heart attacks, strokes, and inflammation with minimal side effects. Key trends in her publications highlight targeted drug delivery , thrombosis prevention , Nanotherapeutics , and translational cardiovascular research . Her studies often explore the intersection of molecular imaging , biomedical engineering , and clinical applications . Scientific awards and recognitions: National Heart Foundation Future Leader Fellowship Level 2 Baker Institute Sir Laurence Muir Prize World Molecular Imaging Society Mid Career Award Inaugural Fellow of the Australian Society of Molecular Imaging National Heart Foundation Paul Korner Innovation Award Inaugural Women of Colour in STEM Award AVBS Achievement and Career Development Award 40 Under 40 Most Influential Asian-Australian Award Finalist Professor Wang is also deeply committed to equity and mentorship, chairing the Baker Institute’s Mentoring Committee and serving on leadership teams for the Women in Molecular Imaging Network and the Gender Equity and Diversity Committee. She has received over 27 national and international travel grants, 18 research prizes, and 14 Young Investigator Awards, underscoring her impact in the field.
Kunlei Liu is a Professor in the Department of Mechanical Engineering and Director of the Institute for Decarbonization and Energy Advancement (IDEA) at the University of Kentucky. He holds a Ph.D. in Thermoenergy Engineering from Southeast University (1993), an M.S. in Thermoenergy Engineering (1991), and a B.S. in Power Engineering (1988), all from Southeast University, Nanjing, PRC. His career includes roles as Associate Director for Research at the Center for Applied Energy Research (CAER) and academic positions at Western Kentucky University, including managing their Combustion Laboratory from 2002–2004. Prior to academia, he worked at The Babcock & Wilcox Company as an Advisory Engineer (2004–2005). Research Interests: Dr. Liu focuses on advanced combustion and gasification technologies, carbon removal from point sources and ambient air, hydrogen production, efficiency optimization, and material recovery from spent batteries and solar panels. His work integrates engineering, environmental science, and electrochemistry to address decarbonization challenges. He actively explores innovations in CO₂ capture solvents, electrochemical processes, and waste valorization strategies. Articles Trends: His recent publications concentrate on CO₂ capture via novel absorbents (e.g., diamine-based and potassium salts), electrochemical methods for CO₂ conversion, solvent degradation mechanisms, and material recovery from spent batteries and solar panels. He also investigates process intensification techniques using 3D-printed structured packing, microbubble technologies, and low-temperature methanation. Key areas include optimizing pilot plant performance, reducing nitrosamine contaminants, and enhancing system efficiency through computational modeling and experimental validation. Grants & Advising: While no advisees are listed, his leadership roles indicate extensive grant-funded research, including projects on decarbonization technologies, formic acid production, and direct air capture. He has managed CAER’s research programs and led interdisciplinary teams in pilot-scale testing and industrial collaborations. Labs & Teams: Dr. Liu directs IDEA and has historically managed the Combustion Laboratory at Western Kentucky University. He collaborates closely with UK’s Center for Applied Energy Research (CAER), focusing on innovative technologies for energy systems and environmental sustainability.
Quim Peña is a postdoctoral researcher at the Department of Experimental Molecular Imaging (RWTH Aachen University). He obtained his PhD in Chemistry from Universitat Autònoma de Barcelona (Spain) and Aix-Marseille Université (France) in 2019, focusing on metal-based chemotherapeutics. Current research focuses on nanomedicine for enhanced drug delivery in cancer therapies Specializes in polymeric micelles and prodrug synthesis Recent work involves RGD-coated microbubbles and ultrasound-mediated delivery Contributed to 89Zr-radiolabeled micelle development for personalized breast cancer treatment His publications (2021-2025) emphasize polymer-drug conjugates , multidrug delivery systems , and theranostic applications . Collaborative projects include collaborations with Twan Lammers, Fabian Kiessling, and Josbert Metselaar. 2025: Hydrophobic ion pairing for micelle drug co-loading 2025: Multidrug micelles for brain tumor treatment 2024: RGD-coated microbubbles for blood-brain barrier delivery 2023: Transformative materials for interfacial drug delivery Scientific recognition includes the 2025 CRS Award for best short talk . His work targets cancer nanomedicine with emphasis on side-effect reduction through advanced delivery systems.
Dr. Tao Sun is an Assistant Professor of Bioengineering at Northeastern University and a core member of the Institute of Chemical Imaging of Living Systems. He joined Northeastern in 2023 after postdoctoral training at Brigham and Women’s Hospital, Harvard School of Engineering and Applied Sciences, and an Instructor role at Harvard Medical School. His research focuses on focused ultrasound (FUS), neuroimaging, and immunoengineering, aiming to treat neurological disorders like glioblastoma and Alzheimer’s disease. He leads the Sun Ultrasound and Neuroengineering (SUN) Lab, developing ultrasound-based therapies and diagnostic tools. Education: Ph.D., Electrical Engineering, Tufts University M.S., Biomedical Engineering, Columbia University B.S., Acoustics, Nanjing University Research Interests: Dr. Sun’s work integrates FUS with drug delivery and immunomodulation. He develops non-invasive methods to enhance drug penetration across the blood-brain barrier and studies ultrasound’s effects on neuroimmune interactions. His lab explores applications in cancer treatment, immunotherapy, and neurodegenerative diseases. Recent breakthroughs include using nonspherical microbubbles for targeted delivery and closed-loop control systems for drug delivery. Awards: Young Investigator Award, Focused Ultrasound Foundation (2022) Young Investigator Award, Acoustical Society of America (2021) Lab & Collaborations: The SUN Lab collaborates with institutions like Harvard and MIT, focusing on ultrasound device innovation and clinical translation. Dr. Sun co-authors high-impact papers in journals like PNAS and Science Translational Medicine , and his work is featured in WIRED and Medical Xpress .
Jason Raymond, Ph.D., is a Research Assistant Professor at the Fralin Biomedical Research Institute (FBRI) at Virginia Tech-Carilion, where he also serves as the Focused Ultrasound Core Manager. He leads advanced research in therapeutic ultrasound and manages state-of-the-art facilities including MRI-guided focused ultrasound systems and a 9.4T small-bore MR-imaging platform. His work supports both preclinical and clinical trials in focused ultrasound applications. Ph.D. in Biomedical Engineering, University of Cincinnati Postdoctoral Research Fellow, University of Oxford Lecturer and Senior Research Associate, Department of Engineering Science, University of Oxford Junior Research Fellow, Kellogg College, Oxford B.S. and M.S. in Engineering Acoustics and Mechanical Engineering, Boston University Dr. Raymond’s research focuses on biomedical therapeutic ultrasound, with applications in drug delivery, blood-brain barrier opening, high-intensity focused ultrasound (HIFU) ablation, and acoustic cavitation. His expertise also extends to ultrasound contrast agents, photoacoustic imaging, and the physical interactions of sound and light in biological tissues. He has pioneered work in sonochemistry, microbubble dynamics, and non-invasive neuromodulation. His recent publications reveal a strong trend in leveraging ultrasound for chemical and biological applications, including sonochemical degradation, hydroxyl radical monitoring, and genetic engineering of biofilms. His work integrates acoustics, chemistry, and biomedical engineering to develop novel therapeutic and diagnostic tools. 38th F.V. Hunt Postdoctoral Research Fellowship, Acoustical Society of America Whitaker International Fellowship, Thoraxcenter–Erasmus Medical Center Junior Research Fellowship, Kellogg College, Oxford Dr. Raymond has been instrumental in establishing physical acoustics laboratories and has contributed to major advancements in focused ultrasound technology. He actively mentors researchers, supports collaborative projects across Virginia Tech, and provides technical guidance for industry and academic partners. His leadership in core facilities enables broad access to cutting-edge ultrasound technologies. He manages the Focused Ultrasound Technical Facilities at FBRI, which include a clinical transcranial MRI-guided focused ultrasound system (InSightec and Siemens) and a Bruker 9.4T MR system for small animal studies. These labs support research in non-invasive surgery, hyperthermia, ablation, and blood-brain barrier modulation.
Nils Sponheim is an Associate Professor at Oslo Metropolitan University (OsloMet) in the Faculty of Technology, Art and Design, Department of Mechanical, Electrical and Chemical Engineering. His research focuses on ultrasound, medical imaging, and signal processing, with particular emphasis on contrast agents, Doppler imaging, and biomedical engineering applications. He has contributed extensively to ultrasound transducer design and problem-based learning pedagogy. Academic Affiliation: OsloMet – Faculty of Technology, Art and Design Research Areas: Ultrasound physics, contrast agent development, Doppler signal analysis, medical imaging instrumentation Education Focus: Problem-Based Learning (PBL) in engineering His publications span transient ultrasonic fields, synchronization techniques for contrast agents, and clinical applications in cardiology and oncology. Key subfields include pulse shaping, frequency resolution limitations, and transducer design. Sponheim's work bridges engineering and clinical diagnostics, with collaborations in cardiology and oncology imaging. Current projects focus on pulsed ultrasonic fields and practical measurement systems.
Professor Robin Cleveland serves as a Professor in the Department of Engineering Science at the University of Oxford and holds a Tutorial Fellowship at Magdalen College, where he has been based since 2011. His academic home is the Institute of Biomedical Engineering, and he actively contributes to both undergraduate teaching and cutting-edge biomedical research. His educational journey began in Rotorua, New Zealand, where he earned BSc and MSc degrees in Physics from the University of Auckland. He then pursued doctoral studies at the University of Texas at Austin, obtaining a PhD in Mechanical Engineering focused on sonic boom propagation from supersonic aircraft. This was followed by a two-year post-doctoral fellowship at the University of Washington in Seattle investigating shock waves for biomedical applications. Prior to Oxford, he spent 14 years on the faculty at Boston University's Department of Mechanical Engineering. Cleveland's research centers on nonlinear acoustics with transformative biomedical applications. His current projects include transcranial ultrasound neurostimulation for modulating brain activity, investigating traumatic brain injury mechanisms, developing high-intensity focused ultrasound techniques to destroy bacterial biofilms, advancing ultrasound-based cancer treatments, and optimizing shock wave lithotripsy for kidney stone fragmentation. His work uniquely bridges engineering physics with clinical medicine to solve complex medical challenges. Analysis of his recent publications reveals a consistent interdisciplinary trajectory where acoustic wave physics is systematically applied to neurological, infectious disease, oncological, and urological conditions. The publications demonstrate increasing sophistication in coupling ultrasound with nanotechnology for drug delivery and leveraging passive acoustic mapping for real-time treatment monitoring, with strong translational focus toward clinical implementation. His scientific recognition includes: Fellow of the Acoustical Society of America Associate Editor of Journal of the Acoustical Society of America Knobbly Knees Award (2013) from the Cuddington Summer Fete Professor Cleveland provides undergraduate instruction through college tutorials in fluid mechanics and thermodynamics at Magdalen College, typically with 2-6 students per session. At the departmental level, he lectures in mathematics and fluid mechanics for undergraduate courses and teaches specialized postgraduate courses in ultrasonics. His research is conducted within the BUBBL (Biomedical Ultrasonics, Biotherapy and Biopharmaceuticals Laboratory) group, which focuses on translating acoustic phenomena into medical therapies through rigorous experimental and computational approaches. He leads a multidisciplinary research team within the Institute of Biomedical Engineering's BUBBL group, collaborating with clinicians, physicists, and biomedical engineers to develop novel ultrasound-based diagnostic and therapeutic platforms. Current team efforts focus on neurostimulation protocols, antibacterial ultrasound applications, and advanced drug delivery systems using acoustic cavitation phenomena.
Mathias FINK is a Professor at ESPCI Paris on the Georges Charpak chair. His research focuses on fundamental wave physics in complex media with major applications in medical imaging, telecommunications, and geophysics. He pioneered time-reversal mirrors for wave focusing and co-founded 6 technology companies. Key Institutions: ESPCI Paris, Collège de France Research Themes: Wave physics, time-reversal techniques, matrix imaging, metasurface design His work spans multi-echo wave systems , ultrasonic therapeutic devices , and adaptive electromagnetic communication systems . Recent publications emphasize 3D matrix imaging in biological tissues and space-time interface dynamics . Scientific recognition includes: First academic elected at Collège de France (2008) Over 400 peer-reviewed publications 70+ patents and 6 start-ups Collaborations extend to Institut des Hautes Études Scientifiques , Langevin Institute , and Hong Kong University of Science and Technology . His team's volcanic imaging work with seismic noise has revolutionized subterranean mapping.
Anxo Vidal Figueroa is an Associate Professor of Physiology at the University of Santiago de Compostela, where he has been a permanent faculty member since 2008. He is affiliated with the Faculty of Medicine and Dentistry, Department of Physiology, and is part of the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). Vidal leads the "MeMoEn" (Molecular Mechanisms of Disease) research group and previously contributed to the "FIFAEC" (Physiology and Pharmacology of Chronic Diseases) group. His academic journey began with a PhD in Cell Biology from the University of Santiago de Compostela in 1997, where he completed his thesis "Functional analysis of prothymosin alpha in cell cultures" under the supervision of Dr. Fernando Domínguez Puente and Dr. M. Clara Alvarez Villamarin. From 1998 to 2003, he pursued postdoctoral research at Memorial Sloan-Kettering Cancer Center in New York, working in the Laboratory of Cell Cycle Regulation under Dr. Andrew Koff. Vidal's research program focuses on understanding the molecular mechanisms of cancer development and progression, with particular emphasis on cell cycle regulation, tumor suppressor biology, and stem cell dynamics. His laboratory employs genetically modified mouse models to investigate how cell cycle regulators control cancer initiation, tissue homeostasis, and aging processes. In recent years, his work has expanded into nanomedicine and novel therapeutic strategies for advanced cancers, particularly through nanocarrier systems and immunotherapy approaches. Analysis of his recent publications reveals a strong trend toward translational cancer research, with increasing focus on nanomedicine applications (2022-2025). His work spans molecular mechanisms of tumor suppressors, cancer stem cell biology, and the development of innovative therapeutic tools including nanoengineered drug delivery systems, silver clusters as antitumoral agents, and immunotherapeutic approaches for pancreatic and ovarian cancers. 2006 Novartis Award in Endocrine Tumor Pathology Ranked #2 nationwide in Physiology for the Spanish "Ramon y Cajal" Program (2002) As a principal investigator, Vidal has secured competitive national and international research grants, including a Retos Colaboración grant with SunRock Biopharma and current grants for immunotherapy against ovarian cancer. He has supervised 16 PhD theses and mentored numerous researchers throughout his career. His laboratory, the Cell Cycle and Oncology group at CIMUS, focuses on five main research areas: mechanisms of p27Kip1 regulation, cooperative functions of cell cycle regulators, cell cycle-independent roles of CDK inhibitors in stem cell biology, molecular relationships between reprogramming and cancer, and development of new therapeutic tools in advanced cancer.
David Maresca is an Associate Professor in the Imaging Physics department at the Faculty of Applied Sciences, Delft University of Technology. His research focuses on the intersection of ultrasound imaging physics and molecular engineering, with the goal of enabling ultrasound imaging of cells across space and time in living opaque organs. His research interests include: Biomolecular acoustic sensors Functional ultrasound neuroimaging Transcranial ultrasound Nonlinear ultrasound imaging Engineering of acoustic biosensors Ultrasound imaging of brain function Dr. Maresca's work centers on developing technologies that combine ultrasound physics with molecular engineering to create new imaging capabilities. His lab pioneers approaches to image cells within opaque organs using ultrasound, with applications in neuroscience and biomedical imaging. His research spans from fundamental ultrasound physics to the development of acoustic biosensors and imaging techniques that can detect cellular processes. His recent publications demonstrate a strong focus on advancing ultrasound imaging capabilities, particularly in nonlinear ultrasound techniques, contrast-enhanced ultrasound, and applications in neuroimaging. His work shows increasing interdisciplinary collaboration across physics, engineering, and neuroscience. Dr. Maresca has received recognition including the HFSP Cross-Disciplinary Fellowship. His academic background includes a Ph.D. in Biomedical Engineering from Erasmus MC, an M.Sc. in Acoustics, and a Master's degree in Physics from Université Paris Diderot. He completed postdoctoral work at Caltech and Institut Langevin, ESPCI. His research is supported by collaborations across institutions, with recent work involving researchers from multiple universities and research centers. Dr. Maresca's lab is actively contributing to advancing ultrasound imaging technology and its applications in biomedical research.
Erick S. Vasquez is an Associate Professor in the Department of Chemical and Materials Engineering at the University of Dayton’s School of Engineering. His research focuses on designing advanced nanocomposite materials, particularly magnetic nanoparticles, for applications in water purification, drug delivery, and biological detection. He actively collaborates with researchers nationwide and internationally, emphasizing interdisciplinary innovation. Dr. Vasquez holds a Ph.D. in Chemical Engineering from Mississippi State University (2013), an M.S. from Clemson University (2009), and a B.S. from Universidad Centroamericana José Simeón Cañas (2007). He is a Senior Member of the American Institute of Chemical Engineers (AIChE) and a member of multiple professional organizations, including the American Chemical Society (ACS) and Sigma Xi. His research interests span nanomaterials synthesis, biomaterials interactions, and engineering education. Notable work includes developing biocompatible magnetic nanoparticles for medical applications and optimizing team-based learning in engineering labs. His studies on optothermal microbubble manufacturing and plasmonic nanostructures have advanced chemical sensing technologies. Dr. Vasquez teaches courses such as Chemical Engineering Unit Operations Laboratory and Transport Phenomena, integrating active learning and entrepreneurial mindset development. He has received recognition for his research, including a 2019 PCCP Hot Article and a 2016 Journal of Nanobiotechnology featured contribution. He has secured grants for projects like assessing global engineering competence through international collaborations and advancing ethanol extraction methods using nanocomposites. His work bridges fundamental science with practical applications, emphasizing sustainability and biomedical innovation.
Jan Haelssig serves as an Assistant Professor in the Department of Chemical and Biological Engineering at the University of Ottawa’s Faculty of Engineering, specializing in computational modeling for sustainable energy systems. His work bridges fundamental fluid dynamics with industrial applications in renewable energy and clean technology development. Education: Ph.D. from University of Ottawa B.A.Sc. from University of Ottawa Research Focus: Dr. Haelssig’s expertise spans Renewable Energy , Process Engineering , and Clean Technologies , with emphasis on computational fluid dynamics for reactor design. His investigations cover multiphase flow systems, combustion dynamics, fluidization processes, and membrane separation technologies, targeting sustainable solutions for energy production and environmental challenges. Publication Trends: Analysis of his 2021-2024 publications reveals dominant themes in CFD simulation (75% of works), renewable energy systems (65%), and waste-to-resource conversion (40%). Key applications include carbon capture via oxy-fuel combustion, enhanced oil recovery, and circular bioeconomy development, demonstrating consistent methodology-driven innovation. Scientific Recognition: No formal awards or fellowships documented in source materials Academic Engagement: While specific advisees aren’t listed, his active publication record suggests ongoing supervision of graduate researchers. Current grant funding isn’t specified, though recent work indicates collaboration with energy and environmental sectors on reactor optimization projects. Research Infrastructure: Computational modeling forms the core methodology evident in publications, implying strong digital infrastructure. No dedicated laboratory facilities are mentioned, though work aligns with the university’s chemical engineering experimental capabilities for validation studies.
Professor Peter Jarvis is a faculty member at Cranfield University, affiliated with the Cranfield Water Science Institute. He holds the academic rank of Professor of Water Science & Technology. His research focuses on advanced water treatment technologies, contaminant removal, and sustainable water management. He earned his BSc in Marine Biology from the University of Liverpool (1995-1998), followed by an MSc in Water and Wastewater Engineering (2001) and a PhD in Water Treatment (2004), both from Cranfield University. Prior to his academic role, he worked at Anglian Water (2004-2005). Current research interests include natural organic matter removal, lead in drinking water, photocatalysis for organic compound removal, and sustainable treatment processes. He collaborates with organizations like the Drinking Water Inspectorate, EPSRC, and various water utilities. His work emphasizes innovative technologies for robust and energy-efficient water treatment systems. Professor Jarvis leads a team of research students exploring topics like microbial water quality, nanobubble applications, and pesticide degradation. His research has produced numerous peer-reviewed articles, focusing on advanced oxidation, coagulation, and microbial monitoring. He has advised on projects addressing regulatory compliance and public health risks, such as lead contamination and microplastics in drinking water. His contributions align with global sustainability goals, particularly in water quality and resource management.
